Showing results (101-110 of 210) with videos related to

Sort By:
Pageof 21
Human Mutation|July 13, 2005
Dysferlin mutations in LGMD2B, Miyoshi myopathy, and atypical dysferlinopathiesKarine Nguyen, Guillaume Bassez, Rafaëlle Bernard, et al.
Journal of Neuromuscular Diseases|November 19, 2016
Laminin α2 Deficiency-Related Muscular Dystrophy Mimicking Emery-Dreifuss and Collagen VI related DiseasesIsabelle Nelson, Tanya Stojkovic, Valérie Allamand, et al.
Neuromuscular Disorders : NMD|October 13, 2012
Expression of myogenic regulatory factors and myo-endothelial remodeling in sporadic inclusion body myositisJulia V Wanschitz, Odile Dubourg, Emmanuelle Lacene, et al.
Archives of Neurology|August 19, 2007
Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypesKarine Nguyen, Guillaume Bassez, Martin Krahn, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 9, 2013
Autologous myoblast transplantation for oculopharyngeal muscular dystrophy: a phase I/IIa clinical studySophie Périé, Capucine Trollet, Vincent Mouly, et al.
Journal of Neuromuscular Diseases|November 14, 2022
LAMA2-Related Muscular Dystrophy: The Importance of Accurate Phenotyping and Brain Imaging in the Diagnosis of LGMDTanya Stojkovic, Marion Masingue, Corinne Métay, et al.
Human Molecular Genetics|November 26, 2025
C-terminal extension of HSPB6 in a family with myopathy and cataractJaakko Sarparanta, Per Harald Jonson, Anna Vihola, et al.
Neuromuscular Disorders : NMD|July 28, 2016
Cross-sectional retrospective study of muscle function in patients with glycogen storage disease type IIIValérie Decostre, Pascal Laforêt, Aleksandra Nadaj-Pakleza, et al.
Journal of Neurology|January 30, 2021
Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: a new gold standard?Damien Roos-Weil, Nicolas Weiss, Amélie Guihot, et al.
Pageof 21